Each year, some children are born with developmental disorders and intellectual disabilities. These conditions are often caused by mutations in specific genes. Sometimes both copies of a gene – one inherited from each parent – need to be mutated for the symptoms to develop. These mutations are known as recessive mutations.

Here, Chia, Zhong, Niwa et al. diagnosed two siblings in their clinical care with a new form of neurological disease that affects the development of the brain and leads to frequent seizures. To test whether the young patients shared a genetic mutation that could explain their condition, the researchers analyzed the DNA of the children and compared the results with the DNA from their parents and healthy siblings. The results showed that the two children with the condition had inherited a recessive mutation in a gene called CAMK2A. The protein this gene encodes helps nerve cells to form connections and communicate with each other, and it has been shown to be essential for learning and memory.

The CAMK2A enzyme is made up of several identical subunits that form a complex. Chia et al. discovered that the mutation prevented these subunits from joining together properly, resulting in a faulty protein. CAMK2A and other related proteins are crucial for the health of the brain in a wide range of animals. Indeed, experiments in Caenorhabditis elegans, a roundworm commonly used to study neurons, confirmed that the mutation inherited by the children indeed caused similar neurological defects in the worms. Taken together, these experiments suggest that the children’s condition is caused by the mutation in both copies of the CAMK2A gene.

For patients born with inherited diseases, it is often difficult to pinpoint exactly which mutation is responsible for the specific disorder. These findings could therefore help pediatric geneticists recognize this newly defined syndrome and reach the correct diagnoses. These results could also be the starting point for studies that look into restoring the activity of the defective CAMK2A protein.More broadly, identifying genes that are critical for the healthy development of the brain could shed light on common neurological conditions, such as epilepsy and autism.

Calcium/calmodulin-dependent protein kinase II (CAMK2) is a calcium-activated serine/threonine kinase that is extremely abundant in the brain, comprising as much as 0.3% of the total brain protein content (Bennett et al., 1983). CAMK2 is highly enriched at the synapses and is necessary for the process of long-term potentiation (LTP), the activity-dependent strengthening and modulation of synaptic activity that is thought to be the molecular basis of some forms of learning and memory (Kandel et al., 2014; Lisman et al., 2002). In humans, there are four genes encoding distinct CAMK2 iso-enzymes. CAMK2A and CAMK2B are the predominant isoforms in the nervous system, with CAMK2A being expressed 3–4 times higher than CAMK2B (Hanson and Schulman, 1992). Each enzyme comprises a kinase domain, a regulatory domain and an association domain. Structurally CAMK2 holoenzymes are homo- or hetero-oligomers, consisting of 12 or 14 CAMK2 subunits (Hudmon and Schulman, 2002b). The holoenzyme assembly requires the carboxy-terminal association domain, which forms stacked pairs of hexameric or heptameric rings with the regulatory and kinase domain projecting radially to interact with other essential proteins for CAMK2 function and localization (Bhattacharyya et al., 2016). In the absence of calcium signalling, CAMK2 is inactive, as the regulatory domain inhibits kinase function (Yang and Schulman, 1999). This auto-inhibition is relieved when calcium-loaded calmodulin binds to the regulatory domain, thereby exposing the kinase domain and allowing it to phosphorylate target substrates (Meador et al., 1993). Ca²⁺-Calmodulin binding also exposes Thr286 on the regulatory domain of CAMK2A, which becomes phosphorylated in trans by adjacent subunits. Once this residue is phosphorylated, the enzyme is persistently active, even in the absence of continual Ca²⁺-Calmodulin signaling (Rich and Schulman, 1998; Stratton et al., 2013). This switch from auto-inhibition to autonomous, persistent activity is thought to constitute a biochemical form of memory, which marks the neuron for having experienced a previous calcium influx (Bhattacharyya et al., 2016; Stratton et al., 2014; Stratton et al., 2013).

Mice that are homozygous null for CAMK2A are viable and display impaired spatial memory and reduced LTP in the hippocampus (Silva et al., 1992a, 1992b). The heterozygous mutant (Camk2a^+/-) show a significant deficit in spatial working memory and contextual fear memory (Frankland et al., 2001; Matsuo et al., 2009). More recently, it was demonstrated that mice with neuron-specific conditional knock-out of CAMK2A similarly displayed learning deficits and defects in LTP that were comparable to the complete knockout mice (Achterberg et al., 2014). These findings suggest that neuron-intrinsic CAMK2A function is indispensable during the period of learning for memory formation. CAMK2 is conserved in invertebrates, such as D. melanogaster and C. elegans, where the kinase also plays critical roles in behavioral and cognitive traits (Cho et al., 1991; Hudmon and Schulman, 2002a; Reiner et al., 1999; Rongo and Kaplan, 1999). In C. elegans, the only CAMK2 is encoded by the unc-43 gene, which is essential for synaptic function (Rongo and Kaplan, 1999). Loss of unc-43 causes worms to have flaccid muscle tone, locomotion defects and spontaneous body contractions that resemble seizures (Reiner et al., 1999).

In pediatric care, global developmental delay in infants is defined as a significant functional delay in two or more developmental domains including gross and fine motor function, speech and language, cognition, social development and personal skills (Quality Standards Subcommittee of the American Academy of Neurology et al., 2003). These defects are detected at an early age in children age five years or under, and can persist throughout life (Shevell, 2008). About 25–50% of identified case are caused by germline genetic changes, including chromosomal abnormalities, copy number variants and monogenic mutations (Srour and Shevell, 2014; van Bokhoven, 2011). For many patients with global neuro-developmental delay, the genetic etiology remains unknown.

Here, we report the identification of a consanguineous family from Jordan with two affected children manifesting global neuro-developmental delay with frequent seizures and convulsions. The two affected siblings had no dysmorphic features but failed to develop the ability to walk or speak (Figure 1A,B, Figure 1—figure supplement 1A). They displayed progressive psychomotor retardation with hypotonic muscles (Supplemental Material, Videos 1 and 2). Electroencephalogram (EEG) analysis revealed abnormal epileptiform transients (Figure 1C, Figure 1—figure supplement 1B), consistent with frequent myoclonic seizures. Magnetic resonance imaging (MRI) scan showed no major structural defects in the brain of proband II:4 (Figure 1—figure supplement 1C). Serum metabolite levels were normal, ruling out potential lysosomal storage disorders.

Figure 1 with 1 supplement see all

Download asset Open asset

Video 1

Download asset

Video 2

Download asset

Assuming autosomal recessive inheritance, we performed identity-by-descent (IBD) homozygosity mapping using genomic DNA from both parents, two affected probands and three healthy siblings. Only one candidate locus greater than 5 cM on chromosome 5 spanning 28 Mb was delineated (Figure 1D, Figure 1—figure supplement 1D). Whole-exome sequencing was subsequently performed on index case II:1. After filtering for variants with low quality and low sequencing coverage, 72 homozygous variants were identified, out of which four lie within the Chr. 5 IBD region (Table 1). Three of the homozygous variants had been previously annotated as known polymorphisms with minor allele frequencies > 0.0001. In addition, healthy individuals who are homozygous for the minor alleles had been identified in genomic sequencing databases such as dbSNP and gnomAD (Figure 1—figure supplement 1E). We therefore filtered out these variants as non-pathogenic. The fourth homozygous variant within the IBD region mapped to the CAMK2A gene (MIM: 114078), resulting in a missense mutation p.His477Tyr that has never been observed in previous large-scale sequencing databases and our in-house ethnically-matched cohort (Figure 1E, Figure 1—figure supplement 1E). Using Sanger sequencing, this private mutation was confirmed to segregate with the disease in all seven family members (Figure 1A,D).

CAMK2A is a neuron-specific, highly abundant serine/threonine kinase that plays critical roles in synaptic plasticity. To understand how neuronal function is affected due to the mutation in CAMK2A, we reprogrammed primary dermal fibroblasts from patient II.4 into iPSCs, differentiated them into neurons and measured population-level neuronal activity using a multi-electrode array (MEA) system (Figure 2A). Compared to H1 embryonic stem cell derived neurons and an unrelated CAMK2A wild-type iPSC control, the patient’s iPSCs were equally efficient in differentiating into mature neurons expressing neuronal markers TUJ1 and MAP2 after 21 days of in vitro differentiation (Figure 2B). When these differentiated neurons were plated on MEA plates to measure spontaneous action potentials, we observed a significant reduction in both the total number of spontaneous spikes (Figure 2C, left) and the mean firing rate (Figure 2C, right) in the patient-derived neurons harboring the p.H477Y mutation compared to the wild-type controls, suggesting that CAMK2A^H477Y causes a profound functional defect in cultured neurons.

Figure 2

Download asset Open asset

The CAMK2A enzyme consists of an N-terminal catalytic kinase domain, a Ca²⁺-calmodulin-binding regulatory domain and a C-terminal association domain (AD) that is necessary for the assembly of the 12- or 14-subunit holoenzyme. The identified mutation, p.H477Y is located in the association domain (Figure 1E) and affects a histidine residue that is invariant across all vertebrate and invertebrate CAMK2A homologues. It is also conserved in other human CAMK2 paralogs with a similar association domain such as CAMK2B, CAMK2D and CAMK2G (Figure 3A, Figure 3—figure supplement 1A). In addition, this mutation is predicted to be deleterious by both SIFT, PolyPhen and MCAP algorithms. Structurally, His477 is located at the dimeric interface that forms part of the extensive interaction surface at the ‘equatorial’ plane of the CAMK2A holoenzyme (Figure 3B). Based on prior findings that CAMK2A oligomerization through its association domain is indispensable for substrate phosphorylation and synaptic localization (Bhattacharyya et al., 2016), we hypothesize that the p.H477Y allele is hypomorphic and that biallelic loss-of-function in CAMK2A is the direct cause for the neurodevelopmental phenotypes in the two probands.

Figure 3 with 1 supplement see all

Download asset Open asset

To measure the oligomerization potential of the CAMK2A^H477Y mutant in cells, we transiently expressed FLAG-tagged wild-type CAMK2A and CAMK2A^H477Y mutant in 293 T cells, which do not express endogenous CAMK2A. A third mutant CAMK2A^H477X, which lacks amino acids 477–489 and thus encodes a truncated association domain, was used as an additional control. Using native lysis conditions that preserve non-covalent macromolecular interactions, we found that wild-type CAMK2A forms a prominent complex with an apparent molecular weight ~1 MDa (Figure 3C, Native-PAGE, lane 2), which is consistent with the 12- or 14- subunit CAMK2A holoenzyme (Bhattacharyya et al., 2016). As compared to wild-type CAMK2A, the ~1 MDa, putatively oligomeric species was drastically reduced for the p.H477Y mutant and was undetectable for the p.H477X mutant (Figure 3C, Native-PAGE, lane 3 and 4 vs. lane 2). Next, we examined the ability of in vitro translated CAMK2A to self-oligomerize in a cell-free system. In contrast to the negative control protein GFP, wild-type FLAG-CAMK2A efficiently co-immunoprecipitated with HA-CAMK2A (Figure 3D, Lane 10 vs 11). This self-association was preserved between CAMK2A^WT and CAMK2A^H477Y (Figure 3D, lanes 12 and 15), but was completely lost between wild-type CAMK2A and the p.H477X mutant (Figure 3D, lane 13). In contrast, we could not detect any self-association between FLAG- CAMK2A^H477Y and HA- CAMK2A^H477Y (Figure 3D, Lane 16). Taken together, these results suggest that the missense p.H477Y partially disrupts the self-association between identical CAMK2A molecules, which had been shown to be required for holoenzyme assembly. The partial loss of function of the p.H477Y mutant, as compared to a more severe mutation p.H477X, is consistent with the observed autosomal recessive inheritance of the disease in the family, where the heterozygous carriers do not display apparent neuro-developmental symptoms.

During the course of this analysis, we noticed that both p.H477Y and p.H477X mutants had reduced protein abundance. This effect on the p.H477Y mutant was, however, subtle and could not readily explain the difference in the CAMK2A oligomer observed in the native gel (Figure 3C, SDS-PAGE). As it is known that in general fully assembled oligomeric complexes have enhanced stability in vivo compared to partially assembled complexes with disrupted folding like CAMK2A^H477Y (Lord, 1996; Oromendia et al., 2012), we hypothesized that the p.H477Y mutant may exhibit reduced stability and undergo proteasomal degradation. To test this, 293T cells were transfected with reporter constructs that encode GFP tagged wild-type and mutant CAMK2A followed by a self-cleaving peptide T2A and mCherry (Figure 3E). The intensity of GFP fluorescence was used as a direct quantitative measure of CAMK2A stability with the mCherry as an internal control for transfection and translational efficiency. We observed a significant reduction in GFP intensity in cells expressing CAMK2A^H477Y and CAMK2A^H477X as compared to wild-type CAMK2A or GFP alone (Figure 3E) despite comparable mCherry fluorescence levels. This reduction was rescued when we treated the cells with MG132, which blocked proteasomal degradation. MG132 treamentled to enhanced accumulation of the p.H477Y and p.H477X mutant, with a greater effect on p.H477X (Figure 3F, lane 3, 4 vs lane 7, 8, Figure 3—figure supplement 1B). By contrast, the level of the wild-type protein was reduced, likely due to the toxic effects of MG132 (Figure 3F, lane 2 vs. lane 6). These results suggest that in addition to causing reduced holoenzyme assembly, the p.H477Y mutation might also directly or indirectly reduce the overall CAMK2A levels by compromising its half-life.

To unequivocally demonstrate the pathogenicity of the p.H477Y allele in vivo, we performed rescue experiments using C. elegans. A single ortholog of CAMK2, encoded by unc-43, is present in the worm genome and its functions in the nervous system are welldocumented (Reiner et al., 1999). To study the neuronal defects caused by loss of unc-43, we focused on motor neuron, DA9, which has its cell body located in the pre-anal ganglion with a dendrite that extends anteriorly and a posteriorly oriented axon extending via a commissure into the dorsal nerve cord, where it proceeds anteriorly to form approximately 25 en passant synapses onto body wall muscles and reciprocal inhibitory neurons (Figure 4A) (Klassen and Shen, 2007; Maeder et al., 2014). Using mCherry-tagged UNC-43, we observed that UNC-43 could be found along the entire DA9 neuron but concentrated at synaptic boutons (Figure 4B). The homologous patient-specific mutation p.H466Y in UNC-43 (homologous to p.H477Y in human CAMK2A) significantly disrupted the synaptic localization of UNC-43 and caused the protein to be dispersed throughout the entire axon (Figure 4B). To test the consequence of UNC-43 mutation on DA9 synaptic function, we used the itr-1 pB promoter to express the fluorescently conjugated synaptic vesicle marker RAB-3 (RAB3::GFP) within DA9 in both the wild-type and unc-43 mutant background. In wild-type animals, RAB-3::GFP accumulated in discrete puncta along the axon of DA9 at stereotyped synaptic locations. In the canonical unc-43(e408) loss-of-function mutant, we observed a reduction in individual pre-synaptic puncta fluorescence intensity as compared to wild-type animals. This phenotype could be rescued by cell-autonomous expression of wild-type unc-43 in DA9. However, expression of unc-43 harboring the homologous patient mutation UNC-43^H466Y failed to rescue this defect (Figure 4C,D). In addition, transgenic expression of human wild-type CAMK2A fully rescued this defect, confirming the high degree of functional conservation between CAMK2A homologs, while the patient-derived human CAMK2A^H477Y failed to do so (Figure 4C, bottom panels). These results suggest that the p.H477Y mutation is defective in supporting pre-synaptic function in C. elegans.

Figure 4

Download asset Open asset

Immediately posterior to the stretch of presynaptic puncta is an asynaptic domain within the DA9 axon that is devoid of any RAB-3::GFP fluorescence in wild-type animals (Figure 4E, top panel). Loss of unc-43 results in the mislocalization of the synaptic marker RAB3::GFP into this asynaptic region (Figure 4E, bottom panel). This defect could also be rescued by cell autonomous expression of either unc-43 or human CAMK2A. Patient derived mutation CAMK2A^H477Y or the worm homologous mutation UNC-43^H466Y both failed to rescue this phenotype (Figure 4E). In addition, expression of UNC-43^H466Y in wild-type animals did not cause any synaptic defect or mislocalizaton of RAB3::GFP, suggesting that the mutation does not have dominant negative effects (Figure 4F).

We further tested if the patient derived mutation in CAMK2A impacted worm locomotor behavior. Null mutants for unc-43 are flaccid in posture and move with a flattened uncoordinated waveform. The animals are variably convulsive, often spontaneously contracting and relaxing their body-wall muscles in brief repeating bursts that resemble seizures (Reiner et al., 1999). We expressed either wild-type UNC-43 or UNC-43^H466Y in the muscles and neurons of unc-43(e408) mutant worms and scored the behavior of young adults in a double-blind experiment. Only the wildtype UNC-43 was able to rescue the movement defects in unc-43(e408) animals, but not UNC-43^H466Y, suggesting that UNC-43^H466Y is not functional (Figure 4G). Together, the data show that CAMK2A^H477Y is a loss-of-function mutation which fails to support synaptic function in vivo.

In summary, we have identified an autosomal recessive neurodevelopmental syndrome characterized by growth delay, frequent seizures and severe intellectual disability that is caused by a biallelic germline loss-of-function mutation in CAMK2A. Mechanistically this mutation disrupts CAMK2A self-oligomerization and holoenzyme assembly via its association domain. Our functional results are consistent with the high degree of evolutionary conservation of the affected residue H477 in CAMK2A orthologs, as well as previous structural data demonstrating that His477 is located in the interface between two stacked CAMK2A subunits, which together form the basic repeat unit of the ring-shaped holoenzyme (Bhattacharyya et al., 2016; Stratton et al., 2014). The pathogenicity of the biallelic p.H477Y mutation is furthered highlighted by rescue experiments in C. elegans, where in contrast to wild-type human CAMK2A the p.H477Y mutant failed to rescue the neuronal and behavioral defect in unc-43 (CAMK2 ortholog) null worms. Together, these data demonstrate that the loss of function of CAMK2A is the most plausible genetic cause for the neurodevelopmental defects observed in the two affected siblings.

CAMK2 plays important and evolutionary conserved roles in synaptic plasticity, neuronal transmission and cognition in near all model organisms examined, and several groups have shown that somatic mutations in human CAMK2 isoforms may contribute to neurological disorders (Ghosh and Giese, 2015; Robison, 2014; Takemoto-Kimura et al., 2017). Notably, a de novo p.E183V mutation in the CAMK2A catalytic domain was shown to cause autism spectrum disorder (Stephenson et al., 2017). This mutation was shown to act in a dominant-negative manner to reduce wild-type CAMK2A auto-phosphorylation and localization to dendritic spines. While this manuscript was under revision, S. Küry et al. reported multiple families with intellectual disability caused by de novo, heterozygous mutations in both CAMK2A and CAMK2B kinase and auto-regulatory domains, which disrupted CAMK2 phosphorylation and caused neuronal migratory defects in murine models (Küry et al., 2017).

Our discovery of a novel neuro-developmental syndrome caused by biallelic CAMK2A mutations further broadens the spectrum of human neurological disorders caused by the CAMK2 family of kinases. To the best of our knowledge, this represents the first Mendelian human disease caused by biallelic CAMK2A mutations. Our functional characterization of the novel mutation p.H477Y in vitro and in vivo also reveal novel insights on how the CAMK2A holoenzyme regulates neuronal function. In contrast to all previously reported mutations in CAMK2A in intellectual disability syndromes, the p.H477Y is located within the C-terminal association domain and results in a partial but significant disruption of self-oligomerization, suggesting that the assembly of CAMK2A oligomers, in addition to its kinase function is required for neuronal function. Interestingly, the CAMK2A^H477Y mutant retains the ability to interact with wild-type CAMK2A but not with itself (Figure 3D). CAMK2A displays very specific cellular and subcellular expression patterns that is important for regulating substrate phosphorylation in cells (Liu and Murray, 2012; Tsui et al., 2005). The p.H477Y missense affects the subcellular localization in neurons and this may affect its ability to function efficiently. These biochemical results provide a mechanistic basis for the autosomal recessive nature of the disease in our family: the p.H477Y allele is hypomorphic and becomes pathogenic when recessively inherited in the homozygous state. We speculate that heterozygous carriers retain sufficient CAMK2A activity for proper neuronal function. As compared to the milder disease phenotypes reported by Kury et. al., the symptoms afflicting the p.H477Y patients likely represent the most severe manifestation of the CAMK2A dysfunction in humans.

Due to the high degree of conservation of CAMK2A across evolution, we employed the established C. elegans unc-43 mutant to prove the pathogenicity of the p.H477Y mutation. UNC-43 is the worm homologue of vertebrate CAMK2. We demonstrated wild-type human CAMK2A could rescue the locomotive defects of the unc-43 mutants, while the p.H477Y mutant failed to do so, likely due to its inability to localize into neuronal synapses (Figure 4). We anticipate this in vivo functional assay in C. elegans to be widely applicable to assess the pathogenicity of newly discovered CAMK2 alleles found in human diseases.

1. 1. Achterberg KG
   2. Buitendijk GH
   3. Kool MJ
   4. Goorden SM
   5. Post L
   6. Slump DE
   7. Silva AJ
   8. van Woerden GM
   9. Kushner SA
   10. Elgersma Y

   (2014) Temporal and region-specific requirements of αCaMKII in spatial and contextual learning

   Journal of Neuroscience 34:11180.

   https://doi.org/10.1523/JNEUROSCI.0640-14.2014

   • PubMed
   • Google Scholar
2. 1. Bennett MK
   2. Erondu NE
   3. Kennedy MB

   (1983)

   Purification and characterization of a calmodulin-dependent protein kinase that is highly concentrated in brain

   The Journal of Biological Chemistry 258:12735–12744.

   • PubMed
   • Google Scholar
3. 1. Bhattacharyya M
   2. Stratton MM
   3. Going CC
   4. McSpadden ED
   5. Huang Y
   6. Susa AC
   7. Elleman A
   8. Cao YM
   9. Pappireddi N
   10. Burkhardt P
   11. Gee CL
   12. Barros T
   13. Schulman H
   14. Williams ER
   15. Kuriyan J

   (2016) Molecular mechanism of activation-triggered subunit exchange in Ca(2+)/calmodulin-dependent protein kinase II

   eLife 5:e13405.

   https://doi.org/10.7554/eLife.13405

   • PubMed
   • Google Scholar
4. 1. Brenner S

   (1974)

   The Genetics of CAENORHABDITIS ELEGANS

   Genetics 77:71.

   • PubMed
   • Google Scholar
5. 1. Cho KO
   2. Wall JB
   3. Pugh PC
   4. Ito M
   5. Mueller SA
   6. Kennedy MB

   (1991) The alpha subunit of type II Ca2+/calmodulin-dependent protein kinase is highly conserved in Drosophila

   Neuron 7:439–450.

   https://doi.org/10.1016/0896-6273(91)90296-C

   • PubMed
   • Google Scholar
6. 1. Frankland PW
   2. O'Brien C
   3. Ohno M
   4. Kirkwood A
   5. Silva AJ

   (2001) Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory

   Nature 411:309–313.

   https://doi.org/10.1038/35077089

   • PubMed
   • Google Scholar
7. 1. Ghosh A
   2. Giese KP

   (2015) Calcium/calmodulin-dependent kinase II and Alzheimer's disease

   Molecular Brain 8:78.

   https://doi.org/10.1186/s13041-015-0166-2

   • PubMed
   • Google Scholar
8. 1. Hanson PI
   2. Schulman H

   (1992) Neuronal Ca2+/calmodulin-dependent protein kinases

   Annual Review of Biochemistry 61:559–601.

   https://doi.org/10.1146/annurev.bi.61.070192.003015

   • PubMed
   • Google Scholar
9. 1. Hu WF
   2. Pomp O
   3. Ben-Omran T
   4. Kodani A
   5. Henke K
   6. Mochida GH
   7. Yu TW
   8. Woodworth MB
   9. Bonnard C
   10. Raj GS
   11. Tan TT
   12. Hamamy H
   13. Masri A
   14. Shboul M
   15. Al Saffar M
   16. Partlow JN
   17. Al-Dosari M
   18. Alazami A
   19. Alowain M
   20. Alkuraya FS
   21. Reiter JF
   22. Harris MP
   23. Reversade B
   24. Walsh CA

   (2014) Katanin p80 regulates human cortical development by limiting centriole and cilia number

   Neuron 84:1240–1257.

   https://doi.org/10.1016/j.neuron.2014.12.017

   • PubMed
   • Google Scholar
10. 1. Hudmon A
    2. Schulman H

    (2002a) Neuronal CA2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function

    Annual Review of Biochemistry 71:473–510.

    https://doi.org/10.1146/annurev.biochem.71.110601.135410

    • PubMed
    • Google Scholar
11. 1. Hudmon A
    2. Schulman H

    (2002b) Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II

    Biochemical Journal 364:593.

    https://doi.org/10.1042/bj20020228

    • PubMed
    • Google Scholar
12. 1. Kandel ER
    2. Dudai Y
    3. Mayford MR

    (2014) The molecular and systems biology of memory

    Cell 157:163–186.

    https://doi.org/10.1016/j.cell.2014.03.001

    • PubMed
    • Google Scholar
13. 1. Klassen MP
    2. Shen K

    (2007) Wnt signaling positions neuromuscular connectivity by inhibiting synapse formation in C. elegans

    Cell 130:704–716.

    https://doi.org/10.1016/j.cell.2007.06.046

    • PubMed
    • Google Scholar
14. 1. Küry S
    2. van Woerden GM
    3. Besnard T
    4. Proietti Onori M
    5. Latypova X
    6. Towne MC
    7. Cho MT
    8. Prescott TE
    9. Ploeg MA
    10. Sanders S
    11. Stessman HAF
    12. Pujol A
    13. Distel B
    14. Robak LA
    15. Bernstein JA
    16. Denommé-Pichon AS
    17. Lesca G
    18. Sellars EA
    19. Berg J
    20. Carré W
    21. Busk ØL
    22. van Bon BWM
    23. Waugh JL
    24. Deardorff M
    25. Hoganson GE
    26. Bosanko KB
    27. Johnson DS
    28. Dabir T
    29. Holla ØL
    30. Sarkar A
    31. Tveten K
    32. de Bellescize J
    33. Braathen GJ
    34. Terhal PA
    35. Grange DK
    36. van Haeringen A
    37. Lam C
    38. Mirzaa G
    39. Burton J
    40. Bhoj EJ
    41. Douglas J
    42. Santani AB
    43. Nesbitt AI
    44. Helbig KL
    45. Andrews MV
    46. Begtrup A
    47. Tang S
    48. van Gassen KLI
    49. Juusola J
    50. Foss K
    51. Enns GM
    52. Moog U
    53. Hinderhofer K
    54. Paramasivam N
    55. Lincoln S
    56. Kusako BH
    57. Lindenbaum P
    58. Charpentier E
    59. Nowak CB
    60. Cherot E
    61. Simonet T
    62. Ruivenkamp CAL
    63. Hahn S
    64. Brownstein CA
    65. Xia F
    66. Schmitt S
    67. Deb W
    68. Bonneau D
    69. Nizon M
    70. Quinquis D
    71. Chelly J
    72. Rudolf G
    73. Sanlaville D
    74. Parent P
    75. Gilbert-Dussardier B
    76. Toutain A
    77. Sutton VR
    78. Thies J
    79. Peart-Vissers L
    80. Boisseau P
    81. Vincent M
    82. Grabrucker AM
    83. Dubourg C
    84. Tan WH
    85. Verbeek NE
    86. Granzow M
    87. Santen GWE
    88. Shendure J
    89. Isidor B
    90. Pasquier L
    91. Redon R
    92. Yang Y
    93. State MW
    94. Kleefstra T
    95. Cogné B
    96. Petrovski S
    97. Retterer K
    98. Eichler EE
    99. Rosenfeld JA
    100. Agrawal PB
    101. Bézieau S
    102. Odent S
    103. Elgersma Y
    104. Mercier S
    105. Undiagnosed Diseases Network
    106. GEM HUGO
    107. Deciphering Developmental Disorders Study

    (2017) De novo mutations in protein kinase genes camk2a and CAMK2B cause intellectual disability

    American Journal of Human Genetics 101:768–788.

    https://doi.org/10.1016/j.ajhg.2017.10.003

    • PubMed
    • Google Scholar
15. 1. Lisman J
    2. Schulman H
    3. Cline H

    (2002) The molecular basis of CaMKII function in synaptic and behavioural memory

    Nature reviews. Neuroscience 3:175–190.

    https://doi.org/10.1038/nrn753

    • PubMed
    • Google Scholar
16. 1. Liu XB
    2. Murray KD

    (2012) Neuronal excitability and calcium/calmodulin-dependent protein kinase type II: location, location, location

    Epilepsia 53:45–52.

    https://doi.org/10.1111/j.1528-1167.2012.03474.x

    • PubMed
    • Google Scholar
17. 1. Lord JM

    (1996) Protein degradation: Go outside and see the proteasome

    Current Biology 6:1067–1069.

    https://doi.org/10.1016/S0960-9822(02)70666-0

    • Google Scholar
18. 1. Maeder CI
    2. San-Miguel A
    3. Wu EY
    4. Lu H
    5. Shen K

    (2014) In vivo neuron-wide analysis of synaptic vesicle precursor trafficking

    Traffic 15:273–291.

    https://doi.org/10.1111/tra.12142

    • PubMed
    • Google Scholar
19. 1. Matsuo N
    2. Yamasaki N
    3. Ohira K
    4. Takao K
    5. Toyama K
    6. Eguchi M
    7. Yamaguchi S
    8. Miyakawa T

    (2009) Neural activity changes underlying the working memory deficit in alpha-CaMKII heterozygous knockout mice

    Frontiers in Behavioral Neuroscience 3:20.

    https://doi.org/10.3389/neuro.08.020.2009

    • PubMed
    • Google Scholar
20. 1. Meador WE
    2. Means AR
    3. Quiocho FA

    (1993) Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures

    Science 262:1718–1721.

    https://doi.org/10.1126/science.8259515

    • PubMed
    • Google Scholar
21. 1. Mello C

    (1995) DNA transformation

    Methods Cell Biology 48:451–482.

    https://doi.org/10.1016/S0091-679X(08)61399-0

    • Google Scholar
22. 1. Oromendia AB
    2. Dodgson SE
    3. Amon A

    (2012) Aneuploidy causes proteotoxic stress in yeast

    Genes & Development 26:2696–2708.

    https://doi.org/10.1101/gad.207407.112

    • PubMed
    • Google Scholar
23. 1. Park IH
    2. Zhao R
    3. West JA
    4. Yabuuchi A
    5. Huo H
    6. Ince TA
    7. Lerou PH
    8. Lensch MW
    9. Daley GQ

    (2008) Reprogramming of human somatic cells to pluripotency with defined factors

    Nature 451:141.

    https://doi.org/10.1038/nature06534

    • PubMed
    • Google Scholar
24. 1. Shevell M
    2. Ashwal S
    3. Donley D
    4. Flint J
    5. Gingold M
    6. Hirtz D
    7. Majnemer A
    8. Noetzel M
    9. Sheth RD
    10. Quality Standards Subcommittee of the American Academy of Neurology
    11. Practice Committee of the Child Neurology Society

    (2003) practice parameter: evaluation of the child with global developmental delay: report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society

    Neurology 60:367–380.

    https://doi.org/10.1212/01.WNL.0000031431.81555.16

    • PubMed
    • Google Scholar
25. 1. Reiner DJ
    2. Newton EM
    3. Tian H
    4. Thomas JH

    (1999) Diverse behavioural defects caused by mutations in Caenorhabditis elegans unc-43 CaM kinase II

    Nature 402:199–203.

    https://doi.org/10.1038/46072

    • PubMed
    • Google Scholar
26. 1. Rich RC
    2. Schulman H

    (1998) Substrate-directed function of calmodulin in autophosphorylation of Ca2+/calmodulin-dependent protein kinase II

    Journal of Biological Chemistry 273:28424–28429.

    https://doi.org/10.1074/jbc.273.43.28424

    • PubMed
    • Google Scholar
27. 1. Robison AJ

    (2014) Emerging role of CaMKII in neuropsychiatric disease

    Trends in Neurosciences 37:653–662.

    https://doi.org/10.1016/j.tins.2014.07.001

    • PubMed
    • Google Scholar
28. 1. Rongo C
    2. Kaplan JM

    (1999) CaMKII regulates the density of central glutamatergic synapses in vivo

    Nature 402:195–199.

    https://doi.org/10.1038/46065

    • PubMed
    • Google Scholar
29. 1. Shevell M

    (2008) Global developmental delay and mental retardation or intellectual disability: conceptualization, evaluation, and etiology

    Pediatric clinics of North America 55:1071–1084.

    https://doi.org/10.1016/j.pcl.2008.07.010

    • PubMed
    • Google Scholar
30. 1. Silva AJ
    2. Paylor R
    3. Wehner JM
    4. Tonegawa S

    (1992a) Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice

    Science 257:206–211.

    https://doi.org/10.1126/science.1321493

    • PubMed
    • Google Scholar
31. 1. Silva AJ
    2. Stevens CF
    3. Tonegawa S
    4. Wang Y

    (1992b) Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice

    Science 257:201–206.

    https://doi.org/10.1126/science.1378648

    • PubMed
    • Google Scholar
32. 1. Srour M
    2. Shevell M

    (2014) Genetics and the investigation of developmental delay/intellectual disability

    Archives of Disease in Childhood 99:386–389.

    https://doi.org/10.1136/archdischild-2013-304063

    • PubMed
    • Google Scholar
33. 1. Stephenson JR
    2. Wang X
    3. Perfitt TL
    4. Parrish WP
    5. Shonesy BC
    6. Marks CR
    7. Mortlock DP
    8. Nakagawa T
    9. Sutcliffe JS
    10. Colbran RJ

    (2017) A novel human CAMK2A mutation disrupts dendritic morphology and synaptic transmission, and causes ASD-related behaviors

    Journal of Neuroscience 37:2216–2233.

    https://doi.org/10.1523/JNEUROSCI.2068-16.2017

    • PubMed
    • Google Scholar
34. 1. Stratton M
    2. Lee IH
    3. Bhattacharyya M
    4. Christensen SM
    5. Chao LH
    6. Schulman H
    7. Groves JT
    8. Kuriyan J

    (2014) Activation-triggered subunit exchange between CaMKII holoenzymes facilitates the spread of kinase activity

    eLife 3:e01610.

    https://doi.org/10.7554/eLife.01610

    • PubMed
    • Google Scholar
35. 1. Stratton MM
    2. Chao LH
    3. Schulman H
    4. Kuriyan J

    (2013) Structural studies on the regulation of Ca2+/calmodulin dependent protein kinase II

    Current Opinion in Structural Biology 23:292–301.

    https://doi.org/10.1016/j.sbi.2013.04.002

    • PubMed
    • Google Scholar
36. 1. Takemoto-Kimura S
    2. Suzuki K
    3. Horigane SI
    4. Kamijo S
    5. Inoue M
    6. Sakamoto M
    7. Fujii H
    8. Bito H

    (2017) Calmodulin kinases: essential regulators in health and disease

    Journal of Neurochemistry 141:808–818.

    https://doi.org/10.1111/jnc.14020

    • PubMed
    • Google Scholar
37. 1. Tsui J
    2. Inagaki M
    3. Schulman H

    (2005) Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation

    Journal of Biological Chemistry 280:9210–9216.

    https://doi.org/10.1074/jbc.M407653200

    • PubMed
    • Google Scholar
38. 1. van Bokhoven H

    (2011) Genetic and epigenetic networks in intellectual disabilities

    Annual Review of Genetics 45:81–104.

    https://doi.org/10.1146/annurev-genet-110410-132512

    • PubMed
    • Google Scholar
39. 1. Xu X
    2. Radulescu C
    3. Utami K
    4. Pouladi M

    (2017a) Obtaining multi-electrode array recordings from human induced pluripotent stem cell–derived neurons

    Bio-Protocol 7:.

    https://doi.org/10.21769/BioProtoc.2609

    • Google Scholar
40. 1. Xu X
    2. Tay Y
    3. Sim B
    4. Yoon SI
    5. Huang Y
    6. Ooi J
    7. Utami KH
    8. Ziaei A
    9. Ng B
    10. Radulescu C
    11. Low D
    12. Ng AYJ
    13. Loh M
    14. Venkatesh B
    15. Ginhoux F
    16. Augustine GJ
    17. Pouladi MA

    (2017b) Reversal of phenotypic abnormalities by crispr/cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells

    Stem Cell Reports 8:619–633.

    https://doi.org/10.1016/j.stemcr.2017.01.022

    • PubMed
    • Google Scholar
41. 1. Yang E
    2. Schulman H

    (1999) Structural examination of autoregulation of multifunctional calcium/calmodulin-dependent protein kinase II

    Journal of Biological Chemistry 274:26199–26208.

    https://doi.org/10.1074/jbc.274.37.26199

    • PubMed
    • Google Scholar

Author details

1. Poh Hui Chia

   Institute of Medical Biology, Immunos, Singapore

   Contribution

   Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing

   Contributed equally with

   Franklin Lei Zhong and Shinsuke Niwa

   For correspondence

   Pohhui.chia@reversade.com

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-8070-112X

2. Franklin Lei Zhong

   1. Institute of Medical Biology, Immunos, Singapore
   2. Institute of Molecular and Cell Biology, Proteos, Singapore

   Contribution

   Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing

   Contributed equally with

   Poh Hui Chia and Shinsuke Niwa

   For correspondence

   franklin.zhong@reversade.com

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-0516-6021

3. Shinsuke Niwa

   1. Frontier Research Institute for Interdisciplinary Sciences, Tohoku University, Sendai, Japan
   2. Graduate School of Life Sciences, Tohoku University, Sendai, Japan

   Contribution

   Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing

   Contributed equally with

   Poh Hui Chia and Franklin Lei Zhong

   Competing interests

   No competing interests declared

4. Carine Bonnard

   Institute of Medical Biology, Immunos, Singapore

   Contribution

   Resources, Formal analysis, Validation, Investigation

   Competing interests

   No competing interests declared

5. Kagistia Hana Utami

   Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore

   Contribution

   Data curation, Validation, Project administration

   Competing interests

   No competing interests declared

6. Ruizhu Zeng

   Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore

   Contribution

   Formal analysis, Investigation

   Competing interests

   No competing interests declared

7. Hane Lee

   1. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States
   2. Department of Human Genetics, David Geffen School of Medicine University of California, Los Angeles, Los Angeles, United States

   Contribution

   Formal analysis, Investigation

   Competing interests

   No competing interests declared

8. Ascia Eskin

   1. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States
   2. Department of Human Genetics, David Geffen School of Medicine University of California, Los Angeles, Los Angeles, United States

   Contribution

   Formal analysis, Investigation

   Competing interests

   No competing interests declared

9. Stanley F Nelson

   1. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States
   2. Department of Human Genetics, David Geffen School of Medicine University of California, Los Angeles, Los Angeles, United States

   Contribution

   Formal analysis, Investigation

   Competing interests

   No competing interests declared

10. William H Xie

    Institute of Medical Biology, Immunos, Singapore

    Contribution

    Data curation, Supervision

    Competing interests

    No competing interests declared

11. Samah Al-Tawalbeh

    Queen Rania Paediatric Hospital, King Hussein Medical Centre, Royal Medical Services, Amman, Jordan

    Contribution

    Formal analysis, Validation, Investigation

    Competing interests

    No competing interests declared

12. Mohammad El-Khateeb

    National Center for Diabetes, Endocrinology and Genetics, Amman, Jordan

    Contribution

    Resources

    Competing interests

    No competing interests declared

13. Mohammad Shboul

    Al-Balqa Applied University, Faculty of Science, Al-Salt, Jordan

    Contribution

    Resources

    Competing interests

    No competing interests declared

14. Mahmoud A Pouladi

    1. Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore
    2. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Contribution

    Resources, Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-9030-0976

15. Mohammed Al-Raqad

    Queen Rania Paediatric Hospital, King Hussein Medical Centre, Royal Medical Services, Amman, Jordan

    Contribution

    Resources, Funding acquisition

    Competing interests

    No competing interests declared

16. Bruno Reversade

    1. Institute of Medical Biology, Immunos, Singapore
    2. Institute of Molecular and Cell Biology, Proteos, Singapore
    3. Department of Paediatrics, National University of Singapore, Singapore, Singapore
    4. Medical Genetics Department, Koç University School of Medicine, Istanbul, Turkey

    Contribution

    Resources

    For correspondence

    bruno@reversade.com

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-4070-7997

• 7,258

  Page views

• 513

  Downloads

• 45

  Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.